| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/23/2002 | CN1332724A N-arylsulfonyl amino acid omega amides |
| 01/23/2002 | CN1332723A Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 01/23/2002 | CN1332722A 2-substituted Retoamides |
| 01/23/2002 | CN1332721A Process for producing acidic N(long-chain acyl) amino acid |
| 01/23/2002 | CN1332711A Vitamin D analogues |
| 01/23/2002 | CN1332640A DDS compounds and method for assaying the same |
| 01/23/2002 | CN1332638A Combination comprising beta-agonist and further antidiabetic agent |
| 01/23/2002 | CN1332636A Composition for prevention and/or |
| 01/23/2002 | CN1332634A Gamma & T cell immunoactivity potentiators containing shiitake mushroom hypha extract |
| 01/23/2002 | CN1332632A Preventives for hepatopathy |
| 01/23/2002 | CN1332630A Pharmaceutical composition for oral administration having therapeutic activity on gastrointestinal disorders |
| 01/23/2002 | CN1332629A Pharmaceutical composition |
| 01/23/2002 | CN1332628A Method of treating sexual disturbances |
| 01/23/2002 | CN1332627A Method of producing vitamin powder |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/23/2002 | CN1332175A Jackfruit cycloalkane triterpenic saponin as one new compound and its application in the treatment of cardiovascular disease |
| 01/23/2002 | CN1332172A Acetamido lactose PEG glycoside and dimer with activity of resisting tumor metastasis |
| 01/23/2002 | CN1332168A 3-substituted pyrido-[4',3':4,5] thieno-[2,3-d] pyrimidine derivatives, their prep. and use |
| 01/23/2002 | CN1332167A Eprosartan dihydrate and its prep. |
| 01/23/2002 | CN1332163A Semi-synthetic taxane having antineoplastic activity |
| 01/23/2002 | CN1332154A Carbamate compound and its prep. |
| 01/23/2002 | CN1332010A Chinese medicine prepn for treating psychosis |
| 01/23/2002 | CN1332007A Powerful pain-stopping aerosol |
| 01/23/2002 | CN1332002A Acne treating capsule |
| 01/23/2002 | CN1331984A External-use trauma treating ointment |
| 01/23/2002 | CN1331981A Medicine for treating traumatic injury and relieving pain |
| 01/23/2002 | CN1331974A Eyesight improving medicine liquid |
| 01/23/2002 | CN1331973A Prepn. of prostaglandin E1 urethra suppository |
| 01/23/2002 | CN1331972A Medicine for preventing and treating white bottom disease of turtle |
| 01/23/2002 | CN1331971A New use of deferketoamine |
| 01/23/2002 | CN1331970A Application of Mandelit in preparing medicine for human and animal toxoplasma disease |
| 01/23/2002 | CN1331969A Antitumor acive matter |
| 01/23/2002 | CN1078210C Watersoluble azole antifungals |
| 01/23/2002 | CN1078208C Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists |
| 01/23/2002 | CN1078088C Solvent extraction process |
| 01/23/2002 | CN1078083C Bone-calcium liquid protein and its preparation method |
| 01/23/2002 | CN1078082C Medicine for acne and preparing method thereof |
| 01/23/2002 | CN1078074C Composition for treating and inhibiting gastric and duodenal ulcers |
| 01/23/2002 | CN1078073C Use of bisphophonates in bone-inhibiting reabsorption after transplantation of orthopedic prosthesis |
| 01/23/2002 | CN1078072C Use of 1 alpha, 24-dihydroxy vitamin D2 |
| 01/23/2002 | CN1078071C Use of pharmaceutical compositions |
| 01/23/2002 | CN1078070C Use of benzo-thiophone derivative in prep. of thrombin-inhibiting medicine |
| 01/22/2002 | USRE37525 Concurrent administration of acetylsalicylic acid, corticosteroid, indomethacin, or ibuprofen antiinflammatory agent and human immunoglobulin g to treat bronchiolitis caused by respiratory syncytial or parainfluenza virus |
| 01/22/2002 | US6340770 Complexes with diamine compounds with diacids |
| 01/22/2002 | US6340761 Amination and dehydrohalogenation with piperidine compounds |
| 01/22/2002 | US6340755 5H-Pyrano[2,3-d: 6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity |
| 01/22/2002 | US6340752 Cleavage of thio group from carbonyl and conversion to lactam ester |
| 01/22/2002 | US6340709 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 01/22/2002 | US6340708 Decreasing arterial pressure |
| 01/22/2002 | US6340706 Antiinflammatory, antiallergic and antiproliferative agents |
| 01/22/2002 | US6340705 Use of α-linolenic acid metabolites for treatment or prevention of cancer |
| 01/22/2002 | US6340704 Cell differentiation inducing amide derivatives, their production and use |
| 01/22/2002 | US6340703 Treatment or prevention of osteoporosis |
| 01/22/2002 | US6340701 Taxanes chemically linked to cell binding agent for delivering to specific cell population in targeted fashion |
| 01/22/2002 | US6340700 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/22/2002 | US6340699 SPLA2 inhibitor compounds for treatment of disease |
| 01/22/2002 | US6340698 Pharmaceutical solution, substantially free of cyclodextrin, for oral administration comprising itraconazole or saperconazole, acid and one or more alcoholic cosolvents |
| 01/22/2002 | US6340696 Administering therapeutically effective amount of combination of (5-aryl-1,2,4-thiadiazol)-3-yl thiourea derivative or (5-aryl-1,2,4-thiadiazol)-3-yl urea derivative and ribavirin and/or interferon |
| 01/22/2002 | US6340695 Rapid onset formulation |
| 01/22/2002 | US6340694 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 01/22/2002 | US6340693 Administering to patient effective amount of prostaglandin i compound |
| 01/22/2002 | US6340692 Injectable anesthetic |
| 01/22/2002 | US6340689 Contacting atypical upper respiratory pathogenic bacteria, especially legionella species, with antibacterially effective amount of composition comprising gemifloxacin compound or antibacterially effective derivative thereof |
| 01/22/2002 | US6340688 Administering to female during menstrual cycle amount of competitive progesterone antagonist which is less than ovulation-inhibiting dose and less than abortion-inductive dose |
| 01/22/2002 | US6340686 Gonadotropin-releasing hormone antagonists |
| 01/22/2002 | US6340685 Antiinflammatory agents |
| 01/22/2002 | US6340684 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 01/22/2002 | US6340681 Useful as analgesics in mammals |
| 01/22/2002 | US6340680 Oxazinoquinolones useful for the treatment of viral infections |
| 01/22/2002 | US6340679 Guanidine derivatives as inhibitors of cell adhesion |
| 01/22/2002 | US6340675 Process for the production of an anticoagulant composition |
| 01/22/2002 | US6340673 Administering at or near a site of a tumor of tumorigenic disease a herpes simplex virus vector lacking an expressible .gamma..sub.1 34.5 gene, whereby the growth of tumor is suppressed |
| 01/22/2002 | US6340672 Parasiticidal formulation and a method of making this formulation |
| 01/22/2002 | US6340671 Stable compositions for parenteral administration and their use |
| 01/22/2002 | US6340587 Treating racemic mixture with acylase; isolating pure enantiomorph of n-protected (1r,4s)-2-azabicyclo(2.2.1)hept-5-en-3-one |
| 01/22/2002 | US6340577 Protein fragments for use in protein targeting |
| 01/22/2002 | US6340485 Compositions and uses thereof |
| 01/22/2002 | US6340482 Administering by mouth adrenergic amine or amines selected from the group consisting of synephrine, hordenine, octopamine, tyramine and n-methyltyramine for suppressing hunger for inducing weight loss |
| 01/22/2002 | US6340481 Administering by mouth to a human formulation comprising adrenergic amine or amines selected from the group consisting of synephrine, hordenine, octopamine, tyramine and n-methyltyramineenhancing physical performance in a human |
| 01/22/2002 | US6340480 Natural composition for the treatment of circulatory conditions |
| 01/22/2002 | US6340476 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 01/22/2002 | US6340475 Extending the duration of drug release within the stomach during the fed mode |
| 01/22/2002 | US6340472 Method for reducing onset time of pharmaceutically active compounds |
| 01/22/2002 | US6340470 Soluble isoflavone composition and method for preparing the same |
| 01/22/2002 | US6340467 Useful as an ointment, balm or salve for wounds |
| 01/22/2002 | US6340463 For the production of both polyclonal and monoclonal antibodies to defined antigenic domains |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | US6340456 For oral hygiene, drugs |
| 01/22/2002 | CA2237971C Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 01/22/2002 | CA2214872C Benzothiophene compounds, compositions and methods |
| 01/22/2002 | CA2209188C Compositions for the treatment of dermatological disorders and methods for their use |
| 01/22/2002 | CA2192424C Novel paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
| 01/22/2002 | CA2102457C Erythromycin derivatives, process for the preparation thereof, and use thereof as medicaments |
| 01/22/2002 | CA2095881C 2-formylpyridine thiosemicarbazone antitumor agents |
| 01/22/2002 | CA2093794C 1'-aminospiro¬isoquinoline-4(1h),3-pyrrolidine|-1,2',3,5'-(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors |
| 01/22/2002 | CA2082820C Derivatives of 6-aminooctahydroindolizinetriol |
| 01/22/2002 | CA2064872C Aryloxymethylcarbonochloridate ester intermediates, their production and use in synthesizing prodrugs and their use therefor |
| 01/22/2002 | CA2051460C Pharmaceutical compounds |
| 01/22/2002 | CA2049882C Process for iodinating or brominating the alpha-methylenic carbon of a secondary amide |
| 01/22/2002 | CA2045597C Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats |